Can Invitae Be the Winner-Take-Most in Genetic Testing?
Well, probably not all the chips, but taking home most of them is certainly possible. Cathie Wood of ARK investment Management has described Invitae(NYSE:NVTA) as operating in a “winner-take-most” market, and identified Invitae as one of the most under-appreciated companies in her ETFs. Invitae is a top 20 holding across the ARK Innovation ETF(NYSEMKT:ARKK) and ARK Genomic Revolution ETF(NYSEMKT:ARKG). Does it belong in your portfolio too?
Image source: Getty Images
What is a winner-take-most market?
…
